Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Third Quarter of 2024
TAIPEI, Nov. 6, 2024 /PRNewswire/ — Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) (“Chunghwa” or “the Company”) today reported... Read more.
Bank Leumi to Report 3Q 2024 Financial Results on November 19, 2024
TEL AVIV, Israel, Nov. 6, 2024 /PRNewswire/ — Bank Leumi (TASE: LUMI) announced today that it will release its Third Quarter 2024 Financial Results on Tuesday,... Read more.
Volta Energy Solutions Hungary pursues ‘The Copper Mark’ award
The “Copper Mark” is the leading assurance framework to promote responsible practices across the copper industry that considers the environmental, social... Read more.
From Wall Street to Web3: How Triskel is Transforming Financial Access
NEW DELHI, Nov. 6, 2024 /PRNewswire/ — In a world where financial systems are showing cracks—from limited access to exclusionary practices—a quiet revolution... Read more.
ATRenew to Report Third Quarter 2024 Financial Results on November 20, 2024
SHANGHAI, Nov. 6, 2024 /PRNewswire/ — ATRenew Inc. (“ATRenew” or the “Company”) (NYSE: RERE), a leading technology-driven pre-owned... Read more.
Groupe Mutuel integrates Ada Health’s AI-powered care navigation into their member experience across Switzerland to support personalized, streamlined access to care
Ada Health’s AI health assessment and care navigation technology is integrated into Groupe Mutuel’s app. It helps members better understand their symptoms... Read more.
GTN bolsters European growth with FCA authorisation
LONDON, Nov. 6, 2024 /PRNewswire/ — GTN, a global fintech redefining investing and trading for all, is proud to announce that it has secured authorisation... Read more.
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing,... Read more.
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing,... Read more.
AMPCO METAL Acquires Schmelzmetall Group to Expand Capabilities and Enhance Customer Offerings
MARLY, Switzerland, Nov. 6, 2024 /PRNewswire/ — AMPCO METAL, a global leader in copper-based alloys, is pleased to announce its acquisition of Switzerland-based... Read more.